Results 191 to 200 of about 495,661 (270)

Significance of Prehospital 12-Lead Electrocardiogram Transmission　- Trial Utilizing an Established Smartphone Communication Application for Acute Stroke Management. [PDF]

Circ Rep
Yamaguchi K, Kawabata Y, Ise T, Sata M.
europepmc   +1 more source

Transformer-based deep learning approach for obstructive sleep apnea detection using single-lead ECG. [PDF]

Front Artif Intell
Almarshad MA, Al-Ahmadi S, Islam S, Soudani A, BaHammam AS.   +4 more
europepmc   +1 more source

Can ChatGPT compete with emergency medicine specialists? A two-stage assessment of ECG interpretation supported by clinical information. [PDF]

BMC Emerg Med
Umit TB, Arslan M, Inan G, Fettahoglu ST, Yildız A, Sarbay I, Taskan H, Biter HI, Sogut O.   +8 more
europepmc   +1 more source

Multi-site cardiac rhythm monitoring via multi-channel SCG system and exercise-induced physiological analysis. [PDF]

Front Physiol
Hu M, Yi H, Yan W, Ren W, Wang J, Qi F.
europepmc   +1 more source

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy, G. Giblin, A. Gray, N. Starr, L. Murphy, D. O'Sullivan, E. Kavanagh, C. Howley, C. Tracey, E. Morrin, A. McDaid, A. Clarke, J.O. O'Neill, E. Joyce, M. O'Connell, N. G. Mahon   +15 more
wiley   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Enhancing Emergency Medicine Resident Education: A Weekly Education Series to Augment Electrocardiogram Education. [PDF]

J Educ Teach Emerg Med
West T, Adam J, Watkins K.
europepmc   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Temporal Variability and Influence of Measurement Conditions of AI-Based Atrial Fibrillation Risk Estimation. [PDF]

J Arrhythm
Hamada S, Amemiya M, Ochida M, Tao S, Kawamura I, Sasano T.   +5 more
europepmc   +1 more source